Filing Details
- Accession Number:
- 0001127602-13-019124
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2013-06-03 18:00:33
- Reporting Period:
- 2013-06-03
- Filing Date:
- 2013-06-03
- Accepted Time:
- 2013-06-03 18:00:33
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
912183 | Cubist Pharmaceuticals Inc | CBST | Pharmaceutical Preparations (2834) | 223192085 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1379970 | C Steven Gilman | 65 Hayden Avenue Lexington MA 02421 | Evp & Chief Scientific Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2013-06-03 | 15,125 | $16.76 | 38,632 | No | 4 | M | Direct | |
Common Stock | Disposition | 2013-06-03 | 15,125 | $54.49 | 23,507 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Options (Right to Buy) | Disposition | 2013-06-03 | 15,125 | $0.00 | 15,125 | $16.76 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
16,125 | 2009-08-15 | 2019-05-15 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 2,479 | Indirect | 401(k) Plan |
Footnotes
- Sold pursuant to a 10(b)5-1 Plan
- This transaction was executed in multiple trades at prices ranging from $53.8500 to $55.1800. The price reported in the table reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares and prices at which the transaction was effected.
- Option vests 6.25% quarterly over a four-year period.